The Reduction of Retroorbital Fat Volume: A Novel Ophthalmologic Benefit of Bariatric Surgery Induced Weight Loss

Sarmiento-Cobos, Mauricio; Rivera, Carlos Eduardo; Valera, Roberto J.; Fonnegra, Cristina Botero; Montorfano, Lisandro; Menzo, Emanuele Lo; Szomstein, Samuel; Rosenthal, Raúl J.

doi:10.1016/j.jamcollsurg.2021.08.014

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Beyond improvements in risk factors relevant to HF, the significant loss of body weight associated with metabolic surgery is also directly associated with reduction in major cardiovascular events in those with HF (184), notably including those with HFpEF (185). Furthermore, mechanistically, metabolic surgery has also been linked to reversing cardiac remodeling with improved systolic and diastolic function (186,187).…”

Section: Considerations On Metabolic Surgery For Diabetes and Hfmentioning

confidence: 99%

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association

Pop‐Busui¹,

Januzzi²,

Bruemmer³

et al. 2022

Preprint

View full text Add to dashboard Cite

Traditionally, the prevention and management of chronic complications in individuals with type 1 (T1D) and type 2 diabetes (T2D) has been focused on of nephropathy, retinopathy, neuropathy, and atherosclerotic cardiovascular disease (including ischemic heart disease, stroke or peripheral vascular disease) (1). However, heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates (2–4). This recognition stems in part from trials focused on cardiovascular safety of newer drugs to treat diabetes. Data also suggest HF may develop in individuals with diabetes even in the absence of hypertension, coronary heart disease, or valvular heart disease and, as such, represents a major cardiovascular complication in this vulnerable population (5). Given that during the past decade, the prevalence of diabetes (particularly T2D) has risen by 30% globally (6) (with prevalence expected to increase further), the burden of HF on the health care system will continue to rise. The scope of this American Diabetes Association (ADA) consensus report with designated representation from the American College of Cardiology (ACC) is to provide clear guidance and to recommend best approaches to general internists, family physicians, and endocrinologists for HF screening, diagnosis, and management in individuals with T1D, T2D, or prediabetes to mitigate the risks of serious complications, leveraging prior policy statements by the ACC (7) and American Heart Association (AHA) (2). This consensus report was developed by the writing group convened by ADA with representation from ACC through a series of conference calls, emails, and independent work from March 2021 through March 2022. Traditionally, the prevention and management of chronic complications in individuals with type 1 (T1D) and type 2 diabetes (T2D) has been focused on of nephropathy, retinopathy, neuropathy, and atherosclerotic cardiovascular disease (including ischemic heart disease, stroke or peripheral vascular disease) (1). However, heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates (2–4). This recognition stems in part from trials focused on cardiovascular safety of newer drugs to treat diabetes. Data also suggest HF may develop in individuals with diabetes even in the absence of hypertension, coronary heart disease, or valvular heart disease and, as such, represents a major cardiovascular complication in this vulnerable population (5). Given that during the past decade, the prevalence of diabetes (particularly T2D) has risen by 30% globally (6) (with prevalence expected to increase further), the burden of HF on the health care system will continue to rise. The scope of this American Diabetes Association (ADA) consensus report with designated representation from the American College of Cardiology (ACC) is to provide clear guidance and to recommend best approaches to general internists, family physicians, and endocrinologists for HF screening, diagnosis, and management in individuals with T1D, T2D, or prediabetes to mitigate the risks of serious complications, leveraging prior policy statements by the ACC (7) and American Heart Association (AHA) (2). This consensus report was developed by the writing group convened by ADA with representation from ACC through a series of conference calls, emails, and independent work from March 2021 through March 2022.

show abstract

Section: Considerations On Metabolic Surgery For Diabetes and Hfmentioning

confidence: 99%

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association

Pop‐Busui¹,

Januzzi²,

Bruemmer³

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

The Reduction of Retroorbital Fat Volume: A Novel Ophthalmologic Benefit of Bariatric Surgery Induced Weight Loss

Abstract: independently associated with WSSQ high .CONCLUSION: Sociodemographic factors negatively impact IS. Further examination of these associations, and effect on outcomes after surgery, is required to better understand barriers patients with obesity encounter.

Cited by 1 publication

References 0 publications

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association

Contact Info

Product

Resources

About